Experimental and ‘in silico’ analysis of the effect of pH on HIV-1 protease inhibitor affinity: Implications for the charge state of the protein ionogenic groups

Bioorganic & Medicinal Chemistry
2012.0

Abstract

The pH dependence of the HIV-1 protease inhibitor affinity was studied by determining the interaction kinetics of a series of inhibitors at three pH values by surface plasmon resonance (SPR) biosensor analysis. The results were rationalized by molecular mechanics based protocols that have as a starting point the structures of the HIV-1 protease inhibitor complexes differing in the protonation states as predicted by our calculations. The SPR experiments indicate a variety of binding affinity pH dependencies which are rather well reproduced by our simulations. Moreover, our calculations are able to pinpoint the possible changes in the charged state of the protein binding site and of the inhibitor that underlie the observed effects of the pH on binding affinity. The combination of SPR and molecular mechanics calculations has afforded novel insights into the pH dependence of inhibitor interactions with their target. This work raises the possibility of designing inhibitors with different pH binding affinity profiles to the ones described here.

Knowledge Graph

Similar Paper

Experimental and ‘in silico’ analysis of the effect of pH on HIV-1 protease inhibitor affinity: Implications for the charge state of the protein ionogenic groups
Bioorganic & Medicinal Chemistry 2012.0
Improved Structure−Activity Relationship Analysis of HIV-1 Protease Inhibitors Using Interaction Kinetic Data
Journal of Medicinal Chemistry 2004.0
Relationships between Structure and Interaction Kinetics for HIV-1 Protease Inhibitors
Journal of Medicinal Chemistry 2002.0
Introduction of Intrinsic Kinetics of Protein–Ligand Interactions and Their Implications for Drug Design
Journal of Medicinal Chemistry 2018.0
A Combined QM/MM Approach to Protein−Ligand Interactions:  Polarization Effects of the HIV-1 Protease on Selected High Affinity Inhibitors
Journal of Medicinal Chemistry 2004.0
Cyclic HIV-1 Protease Inhibitors Derived from Mannitol:  Synthesis, Inhibitory Potencies, and Computational Predictions of Binding Affinities
Journal of Medicinal Chemistry 1997.0
Design and synthesis of potent HIV-1 protease inhibitors incorporating hydroxyprolinamides as novel P2 ligands
Bioorganic & Medicinal Chemistry Letters 2011.0
Design, Synthesis, and Biological Evaluation of Monopyrrolinone-Based HIV-1 Protease Inhibitors
Journal of Medicinal Chemistry 2003.0
Identification of Weak Points of Hepatitis C Virus NS3 Protease Inhibitors Using Surface Plasmon Resonance Biosensor-Based Interaction Kinetic Analysis and Genetic Variants
Journal of Medicinal Chemistry 2014.0
Design and synthesis of highly potent HIV-1 protease inhibitors with novel isosorbide-derived P2 ligands
Bioorganic & Medicinal Chemistry Letters 2014.0